基于MRI影像组学刻画胶质母细胞瘤中AHR表达的关系并构建预后评估预测模型
研究利用TCGA和TCIA中胶质母细胞瘤患者的增强T1WI MRI及临床变量,分析AHR表达的预后价值,并通过mRMR和RFE筛选影像组学特征,构建LR和SVM预测模型。AHR高表达与更差预后相关(多因素校正后HR 1.61,95%CI 1.085-2.39),LR和SVM模型区分AHR表达的AUC分别为0.887和0.872,影像组学评分是影响总生存的关键因素(HR 3.931,95%CI 1.272-12.148)。
要点
- 增强T1WI影像组学模型可区分胶质母细胞瘤AHR表达水平,LR模型AUC 0.887,SVM模型AUC 0.872。
- AHR高表达与更差预后相关,多因素校正后HR 1.61(95%CI 1.085-2.39,P<0.05)。
- 影像组学评分是总生存的关键影响因素,多因素校正后HR 3.931(95%CI 1.272-12.148,P<0.05)。
核心结论
- 影像组学模型能有效区分胶质母细胞瘤AHR表达水平并预测预后,可能作为辅助临床评估和精准治疗的工具。
研究设计与样本
- 研究获取TCGA和TCIA中胶质母细胞瘤患者的增强T1WI MRI及对应临床变量进行分析,采用KM曲线和Cox回归评估AHR表达的预后价值。
诊断标准与关键数值
- LR模型基于三个筛选特征区分AHR表达,AUC为0.887。
- SVM模型基于三个筛选特征区分AHR表达,AUC为0.872。
- AHR表达多因素校正后为不良预后风险因素,HR 1.61(95%CI 1.085-2.39,P<0.05)。
- 影像组学评分多因素校正后为总生存影响因素,HR 3.931(95%CI 1.272-12.148,P<0.05)。
临床应用与阅片要点
- 作者认为影像组学模型可能作为辅助临床评估和精准治疗的工具。
局限性
- 原文未报告局限性
以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。
英文原文(摘要)· 点击展开
PURPOSE: Aryl hydrocarbon receptor (AHR), a crucial molecular marker associated with glioma, is a potential therapeutic target. We aimed to establish a non-invasive predictive model for AHR through radiomics.
METHODS: Contrast-enhanced T1-weighted (T1W) MRI and the corresponding and clinical variables of glioblastoma patients from The Cancer Genome Atlas (TCGA) and The Cancer Imaging Archive (TCIA) were obtained for analysis. KM curves and Cox regression analyses were used to assess the prognostic value of AHR expression. The radiomics features were screened by Max-Relevance and Min-Redundancy (mRMR) and recursive feature elimination (RFE), followed by the construction of two predictive models using logistic regression (LR) and a support vector machine (SVM).
RESULTS: The expression levels of AHR in tumour patients were significantly higher than those in the control group, and higher AHR expression was associated with worse prognosis (P<0.05). AHR remained a risk factor for poor prognosis in glioblastoma after multivariate adjustment (HR: 1.61, 95% CI: 1.085-2.39, P<0.05). The radiomics models constructed using LR and SVM based on three selected features achieved area under the curve (AUC) values of 0.887 and 0.872, respectively. Radiomics score emerged as a key factor influencing overall survival (OS) after multivariate adjustment in the Cox model (HR: 3.931, 95% CI: 1.272-12.148, P < 0.05).
CONCLUSION: The radiomics models could effectively distinguish the expression levels of AHR and predict prognosis in patients with glioblastoma, which may serve as a powerful tool to assist clinical assessment and precision treatment.
引用
- Liu C, Xu D, Meng L, et al. Characterizing the relationship between MRI radiomics and AHR expression and deriving a predictive model for prognostic assessment in glioblastoma. Neuroradiology. 2024. PMID: 38896238. doi:10.1007/s00234-024-03396-x
供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。